Skip Page Header

Home > Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[img]
Preview
PDF (Perspectives on drugs: comorbidity of substance use) - Published Version
475kB

URL: http://emcdda.europa.eu/topics/pods/comorbidity-su...


Comorbidity of substance use and mental health disorders refers to the co-occurrence of a substance use disorder and another mental health disorder in the same individual. In Europe, the presence of psychiatric disorders associated with substance use disorders has become an important issue in drug policy and treatment provision. This is a result of the high prevalence of comorbidity, the complexity of treating it, and its association with poor treatment outcomes for those affected. This analysis explains what comorbidity is, its implications for care, types of service provision available in Europe and considers key issues for the future.

Item Type
Report
Publication Type
Irish-related, International, Guideline, Report
Drug Type
Substances (not alcohol/tobacco)
Intervention Type
Treatment method, Harm reduction
Source
Date
May 2016
Pages
9 p.
Publisher
European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote

Repository Staff Only: item control page